Free Trial

Dynatronics (DYNT) Competitors

Dynatronics logo
$0.08 0.00 (0.00%)
As of 06/27/2025

DYNT vs. BBLG, AEMD, VERO, GCTK, TTOO, IVF, NAOV, NDRA, BJDX, and LGMK

Should you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include Bone Biologics (BBLG), Aethlon Medical (AEMD), Venus Concept (VERO), GlucoTrack (GCTK), T2 Biosystems (TTOO), INVO Fertility (IVF), Nanovibronix (NAOV), ENDRA Life Sciences (NDRA), Bluejay Diagnostics (BJDX), and LogicMark (LGMK). These companies are all part of the "medical equipment" industry.

Dynatronics vs. Its Competitors

Bone Biologics (NASDAQ:BBLG) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Bone Biologics has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500.

In the previous week, Bone Biologics had 5 more articles in the media than Dynatronics. MarketBeat recorded 5 mentions for Bone Biologics and 0 mentions for Dynatronics. Bone Biologics' average media sentiment score of 0.50 beat Dynatronics' score of 0.00 indicating that Bone Biologics is being referred to more favorably in the media.

Company Overall Sentiment
Bone Biologics Neutral
Dynatronics Neutral

Dynatronics has higher revenue and earnings than Bone Biologics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bone BiologicsN/AN/A-$4.11MN/AN/A
Dynatronics$33.60M0.02-$2.70M-$0.78-0.10

34.3% of Bone Biologics shares are held by institutional investors. Comparatively, 4.2% of Dynatronics shares are held by institutional investors. 7.5% of Bone Biologics shares are held by company insiders. Comparatively, 8.0% of Dynatronics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Bone Biologics has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Bone Biologics' return on equity.

Company Net Margins Return on Equity Return on Assets
Bone BiologicsN/A -130.21% -119.39%
Dynatronics -8.35%-41.81%-9.56%

Summary

Bone Biologics and Dynatronics tied by winning 5 of the 10 factors compared between the two stocks.

Get Dynatronics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DYNT vs. The Competition

MetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$812K$255.69M$5.45B$8.91B
Dividend YieldN/AN/A5.35%4.15%
P/E Ratio-0.095.8726.2419.67
Price / Sales0.0281.95409.75112.42
Price / CashN/A196.1225.7827.49
Price / Book0.136.307.875.41
Net Income-$2.70M-$27.18M$3.16B$248.99M
7 Day PerformanceN/A-4.75%2.60%2.85%
1 Month PerformanceN/A-6.86%5.36%5.49%
1 Year PerformanceN/A27.43%31.74%16.97%

Dynatronics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DYNT
Dynatronics
N/A$0.08
flat
N/A-71.1%$812K$33.60M-0.09200
BBLG
Bone Biologics
1.1084 of 5 stars
$6.20
+4.9%
N/A-37.4%$3.22MN/A0.002News Coverage
AEMD
Aethlon Medical
2.5562 of 5 stars
$1.40
-11.4%
$56.00
+3,900.0%
-68.7%$3.18M$570K-0.1110
VERO
Venus Concept
1.4071 of 5 stars
$2.22
flat
N/A-74.7%$3.16M$61.00M-0.03410Gap Up
GCTK
GlucoTrack
1.0277 of 5 stars
$6.24
-1.3%
N/A-99.7%$3.02MN/A-0.115Gap Down
TTOO
T2 Biosystems
2.3366 of 5 stars
$0.13
-9.3%
$5.00
+3,711.0%
-97.3%$2.76M$7.68M0.00180Gap Up
IVF
INVO Fertility
N/A$1.07
-12.3%
N/AN/A$2.64M$6.53M-0.0310Gap Down
NAOV
Nanovibronix
0.2692 of 5 stars
$0.91
-1.6%
N/A-84.8%$2.38M$2.56M-0.0720
NDRA
ENDRA Life Sciences
3.1403 of 5 stars
$3.27
+2.5%
$50.00
+1,429.1%
-100.0%$2.36MN/A-0.0220Positive News
BJDX
Bluejay Diagnostics
0.5982 of 5 stars
$1.60
+2.6%
N/A-95.4%$2.33M$250K0.009Positive News
LGMK
LogicMark
0.3483 of 5 stars
$0.00
flat
N/A-100.0%$2.25M$9.88M0.0020Gap Up

Related Companies and Tools


This page (NASDAQ:DYNT) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners